Izotropic Corporation Showcases IzoView Breast CT Imaging System Advantages

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) has unveiled an educational overview that positions its IzoView Breast CT Imaging System as a superior alternative to existing breast imaging technologies. The IzoView system provides true 3D, ultra-high-resolution imaging without the need for breast compression, aiming to fill the technological gap between digital breast tomosynthesis and MRI. Licensed globally from UC Davis, the IzoView system boasts 100 times greater spatial resolution than MRI, at a reduced cost and with quicker scan times, promising enhanced screening, diagnosis, and treatment planning, especially for women with dense breast tissue.

For further details on the IzoView Breast CT Imaging System, visit https://ibn.fm/NbLB2.